Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Long-acting adrenomedullin derivatives

A technology of adrenomedullin and compounds, which is applied in the field of long-acting adrenomedullin derivatives, can solve problems such as short half-life, and achieve the effect of pharmacological inhibition and long-term sustained action of adverse side effects

Active Publication Date: 2022-04-26
UNIVERSITY OF MIYAZAKI
View PDF34 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Peptides are generally known to have a short half-life in vivo due to metabolic reactions in the body (e.g. blood)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Long-acting adrenomedullin derivatives
  • Long-acting adrenomedullin derivatives
  • Long-acting adrenomedullin derivatives

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0380] The present invention will be described in more detail below using examples. However, the technical scope of the present invention is not limited to these examples.

[0381]

[0382] [Experiment I-1: Synthesis of full-length adrenomedullin derivatives]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

The present invention provides a novel adrenomedullin derivative with long-lasting action, which can maintain the pharmacological effect of adrenomedullin and substantially suppress adverse side effects. As an exemplary embodiment, the present invention relates to a compound represented by formula (I) or a salt thereof, or a hydrate thereof: A-CH 2 -B(I). In formula (I), A is a modification group containing more than one polyethylene glycol group, and B is a peptide part derived from adrenomedullin or its modification having adrenomedullin activity, wherein the peptide part B Linkage to the remainder is through the covalent bonding of the nitrogen atom of its N-terminal alpha amino group to the carbon atom of the methylene group.

Description

technical field [0001] The present invention relates to a long-acting adrenomedullin derivative. Background technique [0002] Adrenomedullin (hereinafter also referred to as "AM") is a biologically active peptide isolated and identified from pheochromocytoma tissue in 1993 (Non-Patent Document 1). At the beginning of discovery, it has been confirmed that AM can exert a strong antihypertensive effect of dilating blood vessels. For example, Patent Document 1 describes a peptide comprising a human AM amino acid sequence that has a hypotensive effect. [0003] Subsequent studies have shown that AM can exert various pharmacological effects such as cardiovascular protection, anti-inflammation, angiogenesis, and tissue repair promotion. In addition, in order to apply the pharmacological action of AM to the treatment of diseases, studies on the administration of AM to patients with various diseases have been conducted. Among them, AM is expected to be useful as a therapeutic dru...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00A61K38/00A61P29/00A61P9/00C07K14/46C12N15/09C12P21/02
CPCC07K14/575A61K47/60A61P29/00A61P37/00A61P9/00A61P9/08A61P9/12A61K38/00C07K14/46C07K19/00C12N15/09C12P21/02A61K38/22
Inventor 北村和雄山崎基生
Owner UNIVERSITY OF MIYAZAKI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products